Related Experiment Video
Updated: Mar 8, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Gene mutations in myeloproliferative neoplasms
Marito Araki1, Soji Morishita, Norio Komatsu
1Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine.
Abstract:
This review outlines recent advances in the understanding of gene alterations and the genetic background associated with myeloproliferative neoplasms (MPNs), as well as describing the roles of these genetic factors in the development of MPNs. JAK2, CALR, and MPL mutations that are specifically found in patients with MPNs have been shown to constitutively activate cytokine receptors. Other mutations that are commonly found in hematopoietic malignancies have been demonstrated to synergize with disease-specific mutations and to accelerate the development of MPN, or to define the disease subtype. However, some of these mutations are found in healthy elderly persons, such that the mechanism of MPN development remains elusive. Further analyses including those for genetic factors associated with the occurrence of MPN will lead to a complete understanding of MPN development.
Insights
Recent advances in myeloproliferative neoplasms (MPNs) reveal key gene mutations like JAK2, CALR, and MPL. Understanding these genetic factors is crucial for MPN development, though some mutations in healthy individuals complicate the full picture.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Myeloproliferative neoplasms (MPNs) are a group of clonal hematopoietic stem cell disorders.
- The genetic landscape of MPNs is complex, involving both disease-specific and common mutations.
Purpose of the Study:
- To review recent advances in understanding gene alterations in MPNs.
- To describe the roles of genetic factors in MPN development and pathogenesis.
Main Methods:
- Review of current literature on genetic mutations in MPNs.
- Analysis of the functional impact of specific mutations (JAK2, CALR, MPL) on cytokine receptor signaling.
- Examination of synergistic effects of common and disease-specific mutations.
Main Results:
- Specific mutations (JAK2, CALR, MPL) constitutively activate cytokine receptors in MPN patients.
- Common mutations in hematopoietic malignancies can accelerate MPN development or define subtypes when combined with specific mutations.
- Some identified mutations are present in healthy elderly individuals, indicating incomplete understanding of MPN etiology.
Conclusions:
- Genetic factors play a significant role in MPN development.
- Further research into genetic factors is essential for a comprehensive understanding of MPN pathogenesis.
- Elucidating the role of mutations found in healthy individuals may reveal critical insights into MPN initiation.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Abnormal Proliferation
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

